Calculation of the disease burden associated with environmental chemical exposures: application of toxicological information in health economic estimation

Philippe Grandjean, Martine Bellanger, Philippe Grandjean, Martine Bellanger

Abstract

Calculation of costs and the Burden of Disease (BoD) is useful in developing resource allocation and prioritization strategies in public and environmental health. While useful, the Disability-Adjusted Life Year (DALY) metric disregards subclinical dysfunctions, adheres to stringent causal criteria, and is hampered by gaps in environmental exposure data, especially from industrializing countries. For these reasons, a recently calculated environmental BoD of 5.18% of the total DALYs is likely underestimated. We combined and extended cost calculations for exposures to environmental chemicals, including neurotoxicants, air pollution, and endocrine disrupting chemicals, where sufficient data were available to determine dose-dependent adverse effects. Environmental exposure information allowed cost estimates for the U.S. and the EU, for OECD countries, though less comprehensive for industrializing countries. As a complement to these health economic estimations, we used attributable risk valuations from expert elicitations to as a third approach to assessing the environmental BoD. For comparison of the different estimates, we used country-specific monetary values of each DALY. The main limitation of DALY calculations is that they are available for few environmental chemicals and primarily based on mortality and impact and duration of clinical morbidity, while less serious conditions are mostly disregarded. Our economic estimates based on available exposure information and dose-response data on environmental risk factors need to be seen in conjunction with other assessments of the total cost for these environmental risk factors, as our estimate overlaps only slightly with the previously estimated environmental DALY costs and crude calculations relying on attributable risks for environmental risk factors. The three approaches complement one another and suggest that environmental chemical exposures contribute costs that may exceed 10% of the global domestic product and that current DALY calculations substantially underestimate the economic costs associated with preventable environmental risk factors. By including toxicological and epidemiological information and data on exposure distributions, more representative results can be obtained from utilizing health economic analyses of the adverse effects associated with environmental chemicals.

Keywords: Attributable risk; Burden of illness; Lead; Mercury; Neurotoxicity; Pesticides.

Conflict of interest statement

Ethics approval and consent to participate

“Not applicable”.

Consent for publication

“Not applicable”.

Competing interests

We declare no competing interests. The first author is an editor of this journal but was not involved in the editorial decisions.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
For individual environmental risks, the costs of exposure-dependent adverse effects can be estimated using health economics methods, and they can then be compared to costs associated with the estimated disease burden in terms of disability adjusted life years

References

    1. World Bank . Investing in health. New York, NY: Oxford university press; 1993. World development report 1993.
    1. Zeckhauser R, Shepard D. Where now for saving lives? Law and Contemporary Problems. 1976:5–45.
    1. Risk Factors Collaborators GBD, Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, Burnett R, Casey D, Coates MM, Cohen A, Delwiche K, Estep K, Frostad JJ, Astha KC, Kyu HH, Moradi-Lakeh M, Ng M, Slepak EL, Thomas BA, Wagner J, Aasvang GM, Abbafati C, Abbasoglu Ozgoren A, Abd-Allah F, Abera SF, Aboyans V, Abraham B, Abraham JP, Abubakar I, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386:2287–2323. doi: 10.1016/S0140-6736(15)00128-2.
    1. Heindel JJ, Newbold R, Schug TT. Endocrine disruptors and obesity. Nat Rev Endocrinol. 2015;11:653–661. doi: 10.1038/nrendo.2015.163.
    1. Legler J, Fletcher T, Govarts E, Porta M, Blumberg B, Heindel JJ, Trasande L. Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European union. J Clin Endocrinol Metab. 2015;100:1278–1288. doi: 10.1210/jc.2014-4326.
    1. Norman RE, Carpenter DO, Scott J, Brune MN, Sly PD. Environmental exposures: an underrecognized contribution to noncommunicable diseases. Rev Environ Health. 2013;28:59–65. doi: 10.1515/reveh-2012-0033.
    1. Cosselman KE, Navas-Acien A, Kaufman JD. Environmental factors in cardiovascular disease. Nat Rev Cardiol. 2015;12:627–642. doi: 10.1038/nrcardio.2015.152.
    1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2224–2260. doi: 10.1016/S0140-6736(12)61766-8.
    1. Cohen J. Health metrics. A controversial close-up of humanity's health. Science. 2012;338:1414–1416. doi: 10.1126/science.338.6113.1414.
    1. Bourget D, Guillemaud T. The hidden and external costs of pesticide use. Sustainable Agric Rev. 2016;19:35–119. doi: 10.1007/978-3-319-26777-7_2.
    1. Pruss-Ustun A, Vickers C, Haefliger P, Bertollini R. Knowns and unknowns on burden of disease due to chemicals: a systematic review. Environ Health. 2011;10:9. doi: 10.1186/1476-069X-10-9.
    1. Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, Toppari J, Zoeller RT. EDC-2: the Endocrine Society's second scientific statement on endocrine-disrupting chemicals. Endocr Rev. 2015;36:E1–E150. doi: 10.1210/er.2015-1010.
    1. Bergman A, Heindel JJ, Jobling S, Kidd KA, Zoeller RT: State of the science of endocrine disrupting chemicals 2012. In.: united National Environment Programme and world health Organization; 2013.
    1. Grandjean P, Landrigan PJ. Developmental neurotoxicity of industrial chemicals. Lancet. 2006;368:2167–2178. doi: 10.1016/S0140-6736(06)69665-7.
    1. Grandjean P, Landrigan PJ. Neurobehavioural effects of developmental toxicity. Lancet Neurol. 2014;13:330–338. doi: 10.1016/S1474-4422(13)70278-3.
    1. Grandjean P. Only one chance. How environmental pollution Iimpairs brain development – and how to protect the brains of the next generation. New York: Oxford University Press; 2013.
    1. Institute of Medicine . Costs of environment-related health effects. Washington DC: National Academy Press; 1981.
    1. Smith KR, Corvalan CF, Kjellstrom T. How much global ill health is attributable to environmental factors? Epidemiology. 1999;10:573–584. doi: 10.1097/00001648-199909000-00027.
    1. Hanley JA. A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health. 2001;55:508–514. doi: 10.1136/jech.55.7.508.
    1. Allen RW, Barn PK, Lanphear BP. Randomized controlled trials in environmental health research: unethical or underutilized? PLoS Med. 2015;12:e1001775. doi: 10.1371/journal.pmed.1001775.
    1. Grandjean P. Science for precautionary decision-making. In: Gee D, Grandjean P, Hansen SF, van den Hove S, MacGarvin M, Martin J, Nielsen G, Quist D, Stanners D, II v, editors. Late lessons from early warnings. Copenhagen: European Environment Agency; 2013. pp. 517–535.
    1. Gwinn MR, Axelrad DA, Bahadori T, Bussard D, Cascio WE, Deener K, Dix D, Thomas RS, Kavlock RJ, Burke TA. Chemical risk assessment: traditional vs public health perspectives. Am J Public Health. 2017;107:1032–1039. doi: 10.2105/AJPH.2017.303771.
    1. Intergovernmental Panel on Climate Change: Guidance notes for lead authors of the IPCC Fourth Assessment Report on addressing uncertainties. 2005.
    1. Hald T, Aspinall W, Devleesschauwer B, Cooke R, Corrigan T, Havelaar AH, Gibb HJ, Torgerson PR, Kirk MD, Angulo FJ, Lake RJ, Speybroeck N, Hoffmann S. World Health Organization estimates of the relative contributions of food to the burden of disease due to selected foodborne hazards: a structured expert elicitation. PLoS One. 2016;11:e0145839. doi: 10.1371/journal.pone.0145839.
    1. Knol AB, Slottje P, van der Sluijs JP, Lebret E. The use of expert elicitation in environmental health impact assessment: a seven step procedure. Environ Health. 2010;9:19. doi: 10.1186/1476-069X-9-19.
    1. Juri P. The Delphi method: substance, context, a critique and an annotated bibliography. Socio Econ Plan Sci. 1971;5:57–71. doi: 10.1016/0038-0121(71)90041-3.
    1. Rescher N. Predicting the future. Albany, NY: State University of New York Press; 1998.
    1. Pruss-Ustun A, Bonjour S, Corvalan C. The impact of the environment on health by country: a meta-synthesis. Environ Health. 2008;7:7. doi: 10.1186/1476-069X-7-7.
    1. Pruss-Ustun A, Wolf J, Corvalan C, Neville T, Bos R, Neira M. Diseases due to unhealthy environments: an updated estimate of the global burden of disease attributable to environmental determinants of health. J Public Health (Oxf). 2017;39:464–475.
    1. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O'connell D, Oxman AD, Phillips B, Schunemann HJ, Edejer T, Varonen H, Vist GE, Williams JWJ, Zaza S. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490. doi: 10.1136/bmj.328.7454.1490.
    1. Schunemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, Williams JWJ, Kunz R, Craig J, Montori VM, Bossuyt P, Guyatt GH. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336:1106–1110. doi: 10.1136/.
    1. World Health Organization . WHO indoor air quality guidelines: household fuel combustion. Geneva: WHO; 2014.
    1. Office of Health Assessment and Translation (OHAT): Handbook for conducting a literature-based health assessment using OHAT approach for systematic review and evidence integration. National Toxicology Program; 2015.
    1. Hass U, Christiansen S, Axelstad M, Boberg J, Andersson A-M, Skakkebaek NE, Bay K, Holbech H, Kinnberg KL, Bjerregaard P. Evaluation of 22 SIN list 2.0 substances according to the Danish proposal on criteria for endocrine disrupters. Copenhagen: Danish Centre on Endocrine Disruption; 2012.
    1. Woodruff TJ. Making it real-the environmental burden of disease. What does it take to make people pay attention to the environment and health? J Clin Endocrinol Metab. 2015;100:1241–1244. doi: 10.1210/jc.2015-1622.
    1. Lam J, Koustas E, Sutton P, Johnson PI, Atchley DS, Sen S, Robinson KA, Axelrad DA, Woodruff TJ. The navigation guide - evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth. Environ Health Perspect. 2014;122:1040–1051.
    1. Vandenberg LN, Agerstrand M, Beronius A, Beausoleil C, Bergman A, Bero LA, Bornehag CG, Boyer CS, Cooper GS, Cotgreave I, Gee D, Grandjean P, Guyton KZ, Hass U, Heindel JJ, Jobling S, Kidd KA, Kortenkamp A, Macleod MR, Martin OV, Norinder U, Scheringer M, Thayer KA, Toppari J, Whaley P, Woodruff TJ, Ruden C. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals. Environ Health. 2016;15:74. doi: 10.1186/s12940-016-0156-6.
    1. Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, DiGangi J, Bellanger M, Hauser R, Legler J, Skakkebaek NE, Heindel JJ. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union. J Clin Endocrinol Metab. 2015;100:1245–1255. doi: 10.1210/jc.2014-4324.
    1. Attina TM, Hauser R, Sathyanarayana S, Hunt PA, Bourguignon JP, Myers JP, DiGangi J, Zoeller RT, Trasande L. Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis. Lancet Diabetes Endocrinol. 2016;4:996–1003. doi: 10.1016/S2213-8587(16)30275-3.
    1. Rice DP, Hodgson TA, Sinsheimer P, Browner W, Kopstein AN. The economic costs of the health effects of smoking, 1984. The Milbank Quarterly. 1986;64:489–547. doi: 10.2307/3349924.
    1. Hodgson TA. Social and economic implications of cancer in the United States. Ann N Y Acad Sci. 1981;363:189–204. doi: 10.1111/j.1749-6632.1981.tb20731.x.
    1. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol. 2000;106:493–499. doi: 10.1067/mai.2000.109426.
    1. Hodgson TA, Meiners MR: Cost-of-illness methodology: a guide to current practices and procedures. The Milbank Memorial Fund quarterly health and Society 1982, 60:429–462.
    1. Salkever DS. Updated estimates of earnings benefits from reduced exposure of children to environmental lead. Environ Res. 1995;70:1–6. doi: 10.1006/enrs.1995.1038.
    1. Schwartz J. Societal benefits of reducing lead exposure. Environ Res. 1994;66:105–124. doi: 10.1006/enrs.1994.1048.
    1. Hanushek EA, Woessmann L. The role of cognitive skills in economic development. J Econ Lit. 2008;46:607–668. doi: 10.1257/jel.46.3.607.
    1. Rollins NC, Bhandari N, Hajeebhoy N, Horton S, Lutter CK, Martines JC, Piwoz EG, Richter LM, Victora CG. Lancet breastfeeding series G: why invest, and what it will take to improve breastfeeding practices? Lancet. 2016;387:491–504. doi: 10.1016/S0140-6736(15)01044-2.
    1. Rabl A, Spadaro JV, Holland M. How much is clean air worth? Calculating the benefits of pollution control. Cambridge: Cambridge University Press; 2014.
    1. van Grinsven HJ, Rabl A, de Kok TM. Estimation of incidence and social cost of colon cancer due to nitrate in drinking water in the EU: a tentative cost-benefit assessment. Environ Health. 2010;9:58. doi: 10.1186/1476-069X-9-58.
    1. Desaigues B, Ami D, Bartczak A, Braun-Kohlová M, Chilton S, Czajkowski M, Farreras V, Hunt A, Hutchison M, Jeanrenaud C, Kaderjak P, Máca V, Markiewicz O, Markowska A, Metcalf S, Navrud S, Nielsen JS, Ortiz R, Pellegrini S, Rabl A, Riera R, Scasny M, Stoeckel ME, Szántó R, Urban J. Economic valuation of air pollution mortality: a 9-country contingent valuation survey of value of a life year. Ecol Indic. 2007;11:902–910. doi: 10.1016/j.ecolind.2010.12.006.
    1. World Health Organization . The Minsk declaration: the life-course approach in the context of health. Copenhagen: World Health Organization, Regional Office for Europe; 2015.
    1. World Health Organization . Ambient air pollution: a global assessment of exposure and burden of disease. Geneva: WHO; 2016.
    1. Attina TM, Trasande L. Economic costs of childhood lead exposure in low- and middle-income countries. Environ Health Perspect. 2013;121:1097–1102.
    1. Tsai PL, Hatfield TH. Global benefits from the phaseout of leaded fuel. J Environ Health. 2011;74:8–14.
    1. Karagas MR, Choi AL, Oken E, Horvat M, Schoeny R, Kamai E, Cowell W, Grandjean P, Korrick S. Evidence on the human health effects of low-level methylmercury exposure. Environ Health Perspect. 2012;120:799–806. doi: 10.1289/ehp.1104494.
    1. Bellanger M, Pichery C, Aerts D, Berglund M, Castano A, Cejchanova M, Crettaz P, Davidson F, Esteban M, Fischer ME, Gurzau AE, Halzlova K, Katsonouri A, Knudsen LE, Kolossa-Gehring M, Koppen G, Ligocka D, Miklavcic A, Reis MF, Rudnai P, Tratnik JS, Weihe P, Budtz-Jorgensen E, Grandjean P. Economic benefits of methylmercury exposure control in Europe: monetary value of neurotoxicity prevention. Environ Health. 2013;12:3. doi: 10.1186/1476-069X-12-3.
    1. Trasande L, Liu Y. Reducing the staggering costs of environmental disease in children, estimated at $76.6 billion in 2008. Health Aff. 2011;30:863–870. doi: 10.1377/hlthaff.2010.1239.
    1. Grandjean P, Pichery C, Bellanger M, Budtz-Jorgensen E. Calculation of mercury's effects on neurodevelopment. Environ Health Perspect. 2012;120:A452. doi: 10.1289/ehp.1206033.
    1. Bender M: Assessing hair mercury levels of women of childbearing age in 9 countries. Brussels: Zero Mercury Working Group 2013: 28.
    1. Trasande L, DiGangi J, Evers DC, Petrlik J, Buck DG, Samanek J, Beeler B, Turnquist MA, Regan K. Economic implications of mercury exposure in the context of the global mercury treaty: hair mercury levels and estimated lost economic productivity in selected developing countries. J Environ Manag. 2016;183:229–235. doi: 10.1016/j.jenvman.2016.08.058.
    1. Sheehan MC, Burke TA, Navas-Acien A, Breysse PN, McGready J, Fox MA. Global methylmercury exposure from seafood consumption and risk of developmental neurotoxicity: a systematic review. Bull World Health Organ. 2014;92:254–269. doi: 10.2471/BLT.12.116152.
    1. Chen A, Yolton K, Rauch SA, Webster GM, Hornung R, Sjodin A, Dietrich KN, Lanphear BP. Prenatal Polybrominated Diphenyl ether exposures and neurodevelopment in U.S. children through 5 years of age: the HOME study. Environ Health Perspect. 2014;122:856–862.
    1. Eskenazi B, Chevrier J, Rauch SA, Kogut K, Harley KG, Johnson C, Trujillo C, Sjodin A, Bradman A. Utero and childhood Polybrominated Diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS study. Environ Health Perspect. 2013;121:257–262. doi: 10.1289/ehp.121-A257.
    1. Herbstman JB, Sjodin A, Kurzon M, Lederman SA, Jones RS, Rauh V, Needham LL, Tang D, Niedzwiecki M, Wang RY, Perera F. Prenatal exposure to PBDEs and neurodevelopment. Environ Health Perspect. 2010;118:712–719. doi: 10.1289/ehp.0901340.
    1. Engel SM, Wetmur J, Chen J, Zhu C, Barr DB, Canfield RL, Wolff MS. Prenatal exposure to organophosphates, Paraoxonase 1, and cognitive development in childhood. Environ Health Perspect. 2011;119:1182–1188. doi: 10.1289/ehp.1003183.
    1. Bouchard MF, Chevrier J, Harley KG, Kogut K, Vedar M, Calderon N, Trujillo C, Johnson C, Bradman A, Barr DB, Eskenazi B. Prenatal exposure to organophosphate pesticides and IQ in 7-year old children. Environ Health Perspect. 2011;119:1189–1195. doi: 10.1289/ehp.1003185.
    1. Rauh V, Arunajadai S, Horton M, Perera F, Hoepner L, Barr DB, Whyatt R. 7-year neurodevelopmental scores and prenatal exposure to Chlorpyrifos, a common agricultural pesticide. Environ Health Perspect. 2011;119:1196–1201. doi: 10.1289/ehp.1003160.
    1. Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE, Soto AM, Woodruff TJ, Vom Saal FS. Endocrine-disrupting chemicals and public health protection: a statement of principles from the Endocrine Society. Endocrinology. 2012;153:4097–4110. doi: 10.1210/en.2012-1422.
    1. Bellanger M, Demeneix B, Grandjean P, Zoeller RT, Trasande L. Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab. 2015;100:1256–1266. doi: 10.1210/jc.2014-4323.
    1. Ravenscroft P, Brammer, H., Richards, K.: Arsenic pollution: a global synthesis. Chichester: Wiley-Blackwell; 2009.
    1. Fleischer NL, Merialdi M, van Donkelaar A, Vadillo-Ortega F, Martin RV, Betran AP, Souza JP. Outdoor air pollution, preterm birth, and low birth weight: analysis of the world health organization global survey on maternal and perinatal health. Environ Health Perspect. 2014;122:425–430.
    1. Guxens M, Ghassabian A, Gong T, Garcia-Esteban R, Porta D, Giorgis-Allemand L, Almqvist C, Aranbarri A, Beelen R, Badaloni C, Cesaroni G, de Nazelle A, Estarlich M, Forastiere F, Forns J, Gehring U, Ibarluzea J, Jaddoe VW, Korek M, Lichtenstein P, Nieuwenhuijsen MJ, Rebagliato M, Slama R, Tiemeier H, Verhulst FC, Volk HE, Pershagen G, Brunekreef B, Sunyer J. Air pollution exposure during pregnancy and childhood autistic traits in four European population-based cohort studies: the ESCAPE project. Environ Health Perspect. 2016;2016:133–140.
    1. Sunyer J, Esnaola M, Alvarez-Pedrerol M, Forns J, Rivas I, Lopez-Vicente M, Suades-Gonzalez E, Foraster M, Garcia-Esteban R, Basagana X, Viana M, Cirach M, Moreno T, Alastuey A, Sebastian-Galles N, Nieuwenhuijsen M, Querol X. Association between traffic-related air pollution in schools and cognitive development in primary school children: a prospective cohort study. PLoS Med. 2015;12:e1001792. doi: 10.1371/journal.pmed.1001792.
    1. Woodruff TJ, Parker JD, Darrow LA, Slama R, Bell ML, Choi H, Glinianaia S, Hoggatt KJ, Karr CJ, Lobdell DT. Methodological issues in studies of air pollution and reproductive health. Environ Res. 2009;109:311–320. doi: 10.1016/j.envres.2008.12.012.
    1. U.S. Environmental Protection Agency: Integrated science assessment of ozone and related photochemical oxidants (final report). U.S. EPA; 2013.
    1. Institute of Medicine . Preterm birth: causes, consequences, and prevention. Washington, DC: National Academies Press; 2007.
    1. Suades-Gonzalez E, Gascon M, Guxens M, Sunyer J. Air pollution and neuropsychological development: a review of the latest evidence. Endocrinology. 2015;156:3473–3482. doi: 10.1210/en.2015-1403.
    1. Driscoll T, Takala J, Steenland K, Corvalan C, Fingerhut M. Review of estimates of the global burden of injury and illness due to occupational exposures. Am J Ind Med. 2005;48:491–502. doi: 10.1002/ajim.20194.
    1. Pasetto R, Comba P, Marconi A. Mesothelioma associated with environmental exposures. Med Lav. 2005;96:330–337.
    1. Ramazzini C. The global health dimensions of asbestos and asbestos-related diseases. Med Lav. 2016;107:75–79.
    1. Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, DiGangi J, Hunt PM, Rudel R, Sathyanarayana S, Bellanger M, Hauser R, Legler J, Skakkebaek NE, Heindel JJ. Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis. Andrology. 2016;4:565–572. doi: 10.1111/andr.12178.
    1. Bartlett ES, Trasande L. Economic impacts of environmentally attributable childhood health outcomes in the European Union. Eur J Pub Health. 2014;24:21–26. doi: 10.1093/eurpub/ckt063.
    1. Trasande L, Malecha P, Attina TM. Particulate matter exposure and preterm birth: estimates of U.S. attributable burden and economic costs. Environ Health Perspect. 2016;124:1913–1918. doi: 10.1289/ehp.1510810.
    1. Hauser R, Skakkebaek NE, Hass U, Toppari J, Juul A, Andersson AM, Kortenkamp A, Heindel JJ, Trasande L. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European union. J Clin Endocrinol Metab. 2015;100:1267–1277. doi: 10.1210/jc.2014-4325.
    1. Chatham-Stephens K, Caravanos J, Ericson B, Sunga-Amparo J, Susilorini B, Sharma P, Landrigan PJ, Fuller R. Burden of disease from toxic waste sites in India, Indonesia, and the Philippines in 2010. Environ Health Perspect. 2013;121:791–796. doi: 10.1289/ehp.1206127.
    1. Trasande L. Further limiting bisphenol a in food uses could provide health and economic benefits. Health Aff. 2014;33:316–323. doi: 10.1377/hlthaff.2013.0686.
    1. Hunt PA, Sathyanarayana S, Fowler PA, Trasande L. Female reproductive disorders, diseases, and costs of exposure to endocrine disrupting Chemicals in the European Union. J Clin Endocrinol Metab. 2016;101:1562–1570. doi: 10.1210/jc.2015-2873.
    1. Woods B, Revill P, Sculpher M, Claxton K. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Health. 2016;19:929–935. doi: 10.1016/j.jval.2016.02.017.
    1. Bertram MY, Lauer JA, De Joncheere K, Edejer T, Hutubessy R, Kieny MP, Hill SR. Cost-effectiveness thresholds: pros and cons. Bull World Health Organ. 2016;94:925–930. doi: 10.2471/BLT.15.164418.
    1. Janesick AS, Blumberg B. Obesogens: an emerging threat to public health. Am J Obstetr Gynecol. 2016;214:559–565. doi: 10.1016/j.ajog.2016.01.182.
    1. Stieb DM, De Civita P, Johnson FR, Manary MP, Anis AH, Beveridge RC, Judek S. Economic evaluation of the benefits of reducing acute cardiorespiratory morbidity associated with air pollution. Environ Health. 2002;1:7. doi: 10.1186/1476-069X-1-7.
    1. Needham LL, Calafat AM, Barr DB. Assessing developmental toxicant exposures via biomonitoring. Basic Clin Pharmacol Toxicol. 2008;102:100–108. doi: 10.1111/j.1742-7843.2007.00185.x.
    1. Chatham-Stephens K, Caravanos J, Ericson B, Landrigan P, Fuller R. The pediatric burden of disease from lead exposure at toxic waste sites in low and middle income countries. Environ Res. 2014;132:379–383. doi: 10.1016/j.envres.2014.04.018.
    1. Blacksmith Institute . The world’s worst pollution problems: assessing health risks at hazardous waste sites. New York: Blacksmith Institute; 2012.
    1. Organization for Economic Cooperation and Development . Chapter 18: Chemicals. Paris: OECD; 2008. OECD environmental outlook to 2030.
    1. Trasande L, Massey RI, DiGangi J, Geiser K, Olanipekun AI, Gallagher L. How developing nations can protect children from hazardous chemical exposures while sustaining economic growth. Health Aff. 2011;30:2400–2409. doi: 10.1377/hlthaff.2010.1217.
    1. Chanel O, Perez L, Kunzli N, Medina S, Aphekom G. The hidden economic burden of air pollution-related morbidity: evidence from the Aphekom project. Eur J Health Econ. 2016;17:1101–1115. doi: 10.1007/s10198-015-0748-z.
    1. Trasande L, Malecha P, Attina TM. Particulate matter exposure and preterm birth: estimates of US attributable burden and economic costs. Environ Health Perspect. 2017;124:1913–18.
    1. Pascal M, Corso M, Chanel O, Declercq C, Badaloni C, Cesaroni G, Henschel S, Meister K, Haluza D, Martin-Olmedo P, Medina S, Aphekom G. Assessing the public health impacts of urban air pollution in 25 European cities: results of the Aphekom project. Sci Total Environ. 2013;449:390–400. doi: 10.1016/j.scitotenv.2013.01.077.
    1. Organization for Economic Cooperation and Development . The cost of air pollution: health impacts of road transport. Paris: OECD; 2014.
    1. Bierkens J, Buekers J, Van Holderbeke M, Torfs R. Health impact assessment and monetary valuation of IQ loss in pre-school children due to lead exposure through locally produced food. Sci Total Environ. 2012;414:90–97. doi: 10.1016/j.scitotenv.2011.10.048.
    1. Perera F, Weiland K, Neidell M, Wang S. Prenatal exposure to airborne polycyclic aromatic hydrocarbons and IQ: estimated benefit of pollution reduction. J Public Health Policy. 2014;35:327–336. doi: 10.1057/jphp.2014.14.
    1. Weiland K, Neidell M, Rauh V, Perera F. Cost of developmental delay from prenatal exposure to airborne polycyclic aromatic hydrocarbons. J Health Care Poor Underserved. 2011;22:320–329.
    1. Brandt S, Perez L, Kunzli N, Lurmann F, Wilson J, Pastor M, McConnell R. Cost of near-roadway and regional air pollution-attributable childhood asthma in Los Angeles County. J Allergy Clin Immunol. 2014;134:1028–1035. doi: 10.1016/j.jaci.2014.09.029.
    1. Brandt SJ, Perez L, Kunzli N, Lurmann F, McConnell R. Costs of childhood asthma due to traffic-related pollution in two California communities. Eur Respir J. 2012;40:363–370. doi: 10.1183/09031936.00157811.

Source: PubMed

3
구독하다